Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis by Seini Moimoi | Jan 18, 2022 | Portfolio News
Sierra Oncology Updates Topline Data Timing for Pivotal Phase 3 Trial of Momelotinib in Myelofibrosis by Seini Moimoi | Jan 18, 2022 | Portfolio News
Vaxcyte Announces Pricing of $100 Million Public Offering by Seini Moimoi | Jan 13, 2022 | Portfolio News
Theseus Pharmaceuticals Announces First Patient Treated with THE-630 in Phase 1/2 Study in Patients with Advanced Gastrointestinal Stromal Tumors (GIST) by Seini Moimoi | Jan 10, 2022 | Portfolio News
Nabriva Therapeutics Provides Business Update and Announces Preliminary Financial Results for the Fourth Quarter of 2021 by Seini Moimoi | Jan 10, 2022 | Portfolio News
Cohere Health Selected as One of Fierce Healthcare’s “Fierce 15” for 2022 by Seini Moimoi | Jan 10, 2022 | Portfolio News
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results by Seini Moimoi | Jan 9, 2022 | Portfolio News
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook by Seini Moimoi | Jan 9, 2022 | Portfolio News
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease by Seini Moimoi | Jan 6, 2022 | Portfolio News
Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue by Seini Moimoi | Jan 6, 2022 | Portfolio News
